Ultrasound guided nerve block for post-operative pain relief in breast cancer surgery:A comparison between two different concentrations of the same drug.

Ultrasound guided Pecs block (I & II) for postoperative analgesia in breast cancer surgery:A prospective, randomized, double blind, comparative study to compare efficacy of 0.375% Ropivacaine versus low concentration 0.2% ropivacaine.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013105

Enrollment

Registered

2018-04-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients diagnosed with breast carcinoma and scheduled for surgery

Interventions

Intervention1: 0.2% Ropivacaine: Administered in Pectoral nerve block (I and II) Control Intervention1: 0.375% Ropivacaine: Administered in Pectoral nerve block (I and II)

Eligibility

Inclusion criteria

Inclusion criteria: 1 ASA class 1 & 2 2 Patient ready to give informed consent

Exclusion criteria

Exclusion criteria: 1 Age 70yrs 2 ASA class >2 3 Respiratory diseases 4 Hepatic diseases 5 Uncontrolled DM 6 Morbid obesity 7 Allery to local anesthetic agent or USG gel 8 H/O chronic pain 9 Drug or alcohol abuse 10 Psychological disorders

Design outcomes

Secondary

Measure	Time frame
Blood pressure, Heart rate, Respiratory rate, Oxygen saturation, Nausea and vomitingTimepoint: 1st hour 2nd hour 4th hour 6th hour 12th hour 24th hour	—

Primary

Measure	Time frame
Postoperative painTimepoint: 1st hour 2nd hour 4th hour 6th hour 12th hour 24th hour	—

Countries

Afghanistan, India, Iraq

Contacts

Public ContactDr UK Valecha

BL Kapur Memorial Hospital

chetansaraya@hotmail.com9871531845

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026